Randomized phase II study of S-1 dosing schedule for resected colorectal cancer

BACKGROUND: Postoperative adjuvant chemotherapy for patients with stage III Colorectal cancer (CRC) is now internationally accepted as standard care for improving patient outcomes. The Adjuvant Chemotherapy Trial of S-1 for Colorectal Cancer (ACTS-CC) confirmed the non-inferiority of S-1 to tegafur/...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuda, Chu, Uemura, Mamoru, Nakata, Ken, Shingai, Tatsushi, Nishimura, Junichi, Hata, Taishi, Ikenaga, Masakazu, Takemasa, Ichiro, Mizushima, Tsunekazu, Kato, Takeshi, Ikeda, Masataka, Ohue, Masayuki, Murata, Kohei, Hasegawa, Junichi, Satoh, Taroh, Yamamoto, Hirofumi, Sekimoto, Mitsugu, Nezu, Riichiro, Doki, Yuichiro, Mori, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470361/
https://www.ncbi.nlm.nih.gov/pubmed/26036466
http://dx.doi.org/10.1186/s12885-015-1476-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470361/
https://www.ncbi.nlm.nih.gov/pubmed/26036466
http://dx.doi.org/10.1186/s12885-015-1476-6

Ejemplares similares